The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
I-PLA2 Activation during Apoptosis Promotes the Exposure of Membrane Lysophosphatidylcholine Leading to Binding by Natural Immunoglobulin M Antibodies and Complement Activation
Open accessAbstract
Deficiency of serum immunoglobulin (Ig)M is associated with the development of a lupus-like disease in mice. Recent studies suggest that classical complement components facilitate the clearance of apoptotic cells and that failure to do so predisposes mice to lupus. Since IgM is a potent activator of the classical complement pathway, we examined IgM binding to dying cells. IgM, but not IgG, bound to apoptotic T cells through the Fab′ portion of the antibody. Exposure of apoptotic cell membranes to phospholipase (PL) A2 increased, whereas PLD reduced, IgM binding and complement activation. Absorption studies combined with direct plate binding assays, revealed that IgM antibodies failed to bind to phosphatidyl lipids, but did recognize lysophosphatidylcholine and the phosphorylcholine head group. Both iPLA2 and cPLA2 are activated during apoptosis. Since inhibition of iPLA2, but not cPLA2, attenuated IgM binding to apoptotic cells, these results strongly suggest that the endogenous calcium independent PLA2, iPLA2, is involved in the hydrolysis of plasma membrane phospholipids and exposure of the epitope(s) recognized by IgM. We propose that recognition of dying cells by natural IgM antibodies is, in part, responsible for complement activation on dying cells leading to their safe clearance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Oxidative stress as a mediator of apoptosis
Buttke, T. M., & Sandstrom, P. A. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90018-3 · Cited by 2,165
Ravetch, J. V., & Bolland, S. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.275 · Cited by 1,657
Natural adjuvants: Endogenous activators of dendritic cells
Gallucci, S., Lolkema, M., & Matzinger, P. (1999) · Nature Medicine · doi:10.1038/15200 · Cited by 1,602
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
Phagocytosis and clearance of apoptotic cells is mediated by MER
Scott, R. S., McMahon, E. J., Pop, S. M., Reap, E. A., Caricchio, R., Cohen, P. L., Earp, H. S., & Matsushima, G. K. (2001) · Nature · doi:10.1038/35075603 · Cited by 1,215 · cited 1×
“The strongest evidence supporting this mechanism is the expression of a lupus-like disease in mice deficient in the tyrosine kinase, mer (2).”
BackgroundThe Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells
Steinman, R. M., Turley, S., Mellman, I., & Inaba, K. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.411 · Cited by 1,172
Ogden, C. A., deCathelineau, A., Hoffmann, P. R., Bratton, D., Ghebrehiwet, B., Fadok, V. A., & Henson, P. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.781 · Cited by 1,147
Repeat-induced gene silencing in mammals
Garrick, D., Fiering, S., Martin, D. I. K., & Whitelaw, E. (1998) · Nature Genetics · doi:10.1038/ng0198-56 · Cited by 887
Features of systemic lupus erythematosus in Dnase1-deficient mice
Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H. G., & Möröy, T. (2000) · Nature Genetics · doi:10.1038/76032 · Cited by 789
Complement-dependent Clearance of Apoptotic Cells by Human Macrophages
Mevorach, D., Mascarenhas, J. O., Gershov, D., & Elkon, K. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2313 · Cited by 700
Self-citationGershov, D., Kim, S., Brot, N., & Elkon, K. B. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1353 · Cited by 695
Self-citationShaw, P. X., Hörkkö, S., Chang, M.-K., Curtiss, L. K., Palinski, W., Silverman, G. J., & Witztum, J. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8472 · Cited by 676
Korb, L. C., & Ahearn, J. M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.10.4525 · Cited by 657
Ly-1 B cells: functionally distinct lymphocytes that secrete IgM autoantibodies.
Hayakawa, K., Hardy, R. R., Honda, M., Herzenberg, L. A., Steinberg, A. D., & Herzenberg, L. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.8.2494 · Cited by 637
Role of natural and immune IgM antibodies in immune responses
Boes, M. (2000) · Molecular Immunology · doi:10.1016/s0161-5890(01)00025-6 · Cited by 602
Palinski, W., Hörkkö, S., Miller, E., Steinbrecher, U. P., Powell, H. C., Curtiss, L. K., & Witztum, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118853 · Cited by 559
Delineating the Genetic Basis of Systemic Lupus Erythematosus
Wakeland, E. K., Liu, K., Graham, R. R., & Behrens, T. W. (2001) · Immunity · doi:10.1016/s1074-7613(01)00201-1 · Cited by 556
Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
Bickerstaff, M. C. M., Botto, M., Hutchinson, W. L., Herbert, J., Tennent, G. A., Bybee, A., Mitchell, D. A., Cook, H. T., Butler, P. J. G., Walport, M. J., et al. (1999) · Nature Medicine · doi:10.1038/9544 · Cited by 489
Reactive Oxygen Species Regulate Activation-Induced T Cell Apoptosis
Hildeman, D. A., Mitchell, T., Teague, T. K., Henson, P., Day, B. J., Kappler, J., & Marrack, P. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80072-2 · Cited by 482
Briles, D. E., Nahm, M., Schroer, K., Davie, J., Baker, P., Kearney, J., & Barletta, R. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.3.694 · Cited by 464
Chang, M.-K., Bergmark, C., Laurila, A., Hörkkö, S., Han, K.-H., Friedman, P., Dennis, E. A., & Witztum, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6353 · Cited by 459
Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R. M., & Beg, A. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7128 · Cited by 432
Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM
Boes, M., Schmidt, T., Linkemann, K., Beaudette, B. C., Marshak-Rothstein, A., & Chen, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1184 · Cited by 370
Balsinde, J., & Dennis, E. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.6758 · Cited by 351
Hörkkö, S., Miller, E., Dudl, E., Reaven, P., Curtiss, L. K., Zvaifler, N. J., Terkeltaub, R., Pierangeli, S. S., Branch, D. W., Palinski, W., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118854 · Cited by 348
Hazen, S. L., Zupan, L. A., Weiss, R. H., Getman, D. P., & Gross, R. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89634-3 · Cited by 303
Normal, Autoimmune, And Malignant Cd5+ B Cells: The Ly-1 B Lineage
Hayakawa, K., & Hardy, R. R. (1988) · Annual Review of Immunology · doi:10.1146/annurev.immunol.6.1.197 · Cited by 301
Structure and Function of Natural Antibodies
Casali, P., & Schettino, E. W. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-85226-8_17 · Cited by 287
Balsinde, J., Bianco, I. D., Ackermann, E. J., Conde-Frieboes, K., & Dennis, E. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8527 · Cited by 287
Phospholipase A2s in Cell Injury and Death
Cummings, B. S., McHowat, J., & Schnellmann, R. G. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39138-4 · Cited by 261
The Role Of Somatic Mutation In The Pathogenic Anti-DNA Response
Diamond, B. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.731 · Cited by 247
Deficiency in Serum Immunoglobulin (Ig)m Predisposes to Development of Igg Autoantibodies
Ehrenstein, M. R., Cook, H. T., & Neuberger, M. S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1253 · Cited by 246
Interaction of C-reactive protein with artificial phosphatidylcholine bilayers
Volanakis, J. E., & Wirtz, K. W. A. (1979) · Nature · doi:10.1038/281155a0 · Cited by 236
Atsumi, G.-I., Tajima, M., Hadano, A., Nakatani, Y., Murakami, M., & Kudo, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.22.13870 · Cited by 235
Ehrenstein, M. R., O’Keefe, T. L., Davies, S. L., & Neuberger, M. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.10089 · Cited by 224
Balsinde, J., Balboa, M. A., & Dennis, E. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.46.29317 · Cited by 220
Wissing, D., Mouritzen, H., Egeblad, M., Poirier, G. G., & Jäättelä, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5073 · Cited by 207
Price, B. E., Rauch, J., Shia, M. A., Walsh, M. T., Lieberthal, W., Gilligan, H. M., O'Laughlin, T., Koh, J. S., & Levine, J. S. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.2201 · Cited by 206
Atsumi, G.-I., Murakami, M., Kojima, K., Hadano, A., Tajima, M., & Kudo, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000271200 · Cited by 173
STUDIES OF ACUTE PHASE PROTEIN
Kushner, I., & Kaplan, M. H. (1961) · The Journal of Experimental Medicine · doi:10.1084/jem.114.6.961 · Cited by 163
Casiano, C. A., Ochs, R. L., & Tan, E. M. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400336 · Cited by 161
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
Vaishnaw, A. K., Orlinick, J. R., Chu, J., Krammer, P. H., Chao, M. V., & Elkon, K. B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5121 · Cited by 154
Self-citationAtsumi, G.-I., Murakami, M., Tajima, M., Shimbara, S., Hara, N., & Kudo, I. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00082-9 · Cited by 115
Gharavi, A. E., Harris, E. N., Lockshin, M. D., et al. (1988) · Annals of the Rheumatic Diseases · doi:10.1136/ard.47.4.286 · Cited by 65
Crossreactivity of Human Anti-dsDNA Antibodies to Phosphorylcholine: Clues to Their Origin
Sharma, A., Isenberg, D. A., & Diamond, B. (2001) · Journal of Autoimmunity · doi:10.1006/jaut.2001.0514 · Cited by 30
Celli, C. M., Gharavi, A. E., & Chaimovich, H. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(98)00225-9 · Cited by 19
Cited by
Dennis, E. A., Cao, J., Hsu, Y.-H., Magrioti, V., & Kokotos, G. (2011) · Chemical Reviews · doi:10.1021/cr200085w · Cited by 1,203
Phagocyte partnership during the onset and resolution of inflammation
Soehnlein, O., & Lindbom, L. (2010) · Nature Reviews Immunology · doi:10.1038/nri2779 · Cited by 1,054
Lauber, K., Bohn, E., Kröber, S. M., Xiao, Y.-J., Blumenthal, S. G., Lindemann, R. K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00422-7 · Cited by 967
Autoimmunity and the Clearance of Dead Cells
Nagata, S., Hanayama, R., & Kawane, K. (2010) · Cell · doi:10.1016/j.cell.2010.02.014 · Cited by 890
The clearance of dead cells by efferocytosis
Boada-Romero, E., Martinez, J., Heckmann, B. L., & Green, D. R. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0232-1 · Cited by 876
Metadata
- Authors
- Kim, S. J., Gershov, D., Ma, X., Brot, N., & Elkon, K. B.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-08-26
- Volume
- 196
- Issue
- 5
- Pages
- 655-665
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2144298599
- Cited by
- 282
- References
- 48
- FWCI
- 16.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.